Although a proposal by the HHS to shift certain prescription drugs from Medicare Part B to Part D may reduce total drug spending by 6.9% to 18.3%, it could also increase out-of-pocket costs for some Medicare beneficiaries, according to a study published in JAMA Internal Medicine.
“The HHS policy blueprint was published on May 11, 2018,” Thomas J. Hwang, AB, of the Program on Regulation, Therapeutics, and Law, division of pharmacoepidemiology and pharmacoeconomics, in the department of medicine at Brigham and Women’s Hospital, Harvard Medical School, and colleagues wrote. “The
Uncategorized